Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.48 EUR | +2.48% | -0.80% | +2.90% |
22/04 | BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment | MT |
11/04 | Gerresheimer shares down on outlook, but key contracts confirmed | RE |